Latest Breaking News On - Benitech biopharma - Page 1 : comparemela.com

ResearchAndMarkets.com’s offering. Gene Therapy Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global gene therapy market. Major players in the gene therapy market are Novartis AG, Bluebird Bio, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.V., Celgene Corporation, Cellectis S.A. and Sangamo Therapeutics. The global gene therapy market is expected to decline from $3.22 billion in 2019 to $3.18 billion in 2020 at a compound annual growth rate (CAGR) of -1.30%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The market is then expected to recover and reach $6.84 billion in 2023 at a CAGR

United statesUnited kingdomBenitech biopharmaGensight biologicsOxford biomedicaLaura woodRegenxbio incEpeius biotechnologies corpTaxus cardium pharmaceuticals group incCelgene corporationShanghai sunway biotech co ltdBristol myers suibb companySarepta therapeutics incBluebird bio incShrine plcGenetic technologies corporation